New Clinsys name reflects global research

Clinsys (Berkeley Heights, New Jersey), a company offering pharma and biotech companies clinical research services in support of Phase I-IV drug development, has renamed itself Clinsys Clinical Research.

David Williams, CEO of Clinsys, said, "In order to effectively meet the expectations of our sponsors we have integrated our global operations under one platform giving us increased capabilities with greater efficiency and enhanced quality. We continue to pursue our strategy to extend our global reach and to expand in our key therapeutic areas of oncology, cardiovascular, central nervous system, dermatology, respiratory and allergy/immunology."

Clinsys has offices in the U.S. and India.